Overcoming toxicities: are IL-2 smart cytokines the next big thing?
IL-2 cytokine therapy was first approved for kidney cancer in 1992, to stop the spread of cancer cells in patients. But quickly enough, its safety was questioned. Now, a more advanced form of this therapy called IL-2 smart cytokines, or superkines, is …